Rare diseases
Investigational molecules
Locations
3rd Floor, 1 Ashley Road, WA14 2DT, United Kingdom
Clinical research activity includes narcolepsy and idiopathic hypersomnia, with a focus on symptoms linked to excessive daytime sleepiness and impaired wakefulness. The trials also address long-term treatment considerations in these central disorders of hypersomnolence.
Research in this area is centered on therapeutic options for chronic sleep-related conditions that affect alertness and daily functioning.
Centessa Pharmaceuticals UK Limited runs clinical trials in conditions such as Narcolepsy, Hypersomnia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
